The QUAMED director Ed Vreeke participates in the Joint UNICEF, UNFPA and WHO meeting with manufacturers and suppliers in Copenhagen ( 28 November-01 December 2022). The title of the meeting is Global Health Supplies: Paradigm Shifts in Market Authorization, Procurement and Supply Chains Approach. We are represented to learn more about the quality assurance systems of suppliers and the QA needs of procurers ...
The Utrecht WHO Collaborating Centre for Pharmaceutical Policy and Regulation is inviting researchers in the field of pharmaceutical policy analysis and regulatory science on 11-12 January 2023 for a Winter meeting, with keynote lectures to be delivered around the central theme of evidence generation along the drug life cycle and a thesis defence from Tina ...
QUAMED is part of the World Health Organization’s Coalition of Interested Parties As formulated by the WHO: “The purpose of CIP is to establish and promote a unified, strategic and coordinated approach to national and regional RSS, with a view to enhancing access to safe, effective and quality medical products”. This aligns perfectly with our vision and ...
The WHO Medical Product Alert refers to 8 sub-standard products, identified in South-East Asia. These products were identified in Indonesia and reported by the natural regulatory authority (Badan POM) on 20 and 30 Oct 2022. The 8 products were: Termorex syrup, Flurin DMP syrup, Unibebi Cough Syrup, Unibebi Demam Paracetamol Drops, Unibebi Demam Paracetamol Syrup, ...
Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.
En poursuivant votre visite sur ce site, vous acceptez l'utilisation de cookies En savoir plus
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.